d2fb993580fab2a389e3d9e33b576722  fonc-14-1472463_2_.pdf
3b987ceb2f89d5f0fb173c807b9160c75973900f  fonc-14-1472463_2_.pdf
30db5872c9a1fbdbe62b30ff2613e30bc6252c40c6e8f19638ae2ee8183cebb9  fonc-14-1472463_2_.pdf

Title:           Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies
Subject:         de Lima M, Di Rocco A and Ribera J-M (2024) Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies. Front. Oncol. 14:1472463
Keywords:        chimeric antigen receptor (CAR T), leukemia, myeloma, lymphoma, toxicity
Author:          Marcos de Lima
CreationDate:    Fri Aug 16 00:44:01 2024 CEST
ModDate:         Fri Aug 16 01:18:34 2024 CEST
Custom Metadata: no
Metadata Stream: yes
Tagged:          no
UserProperties:  no
Suspects:        no
Form:            none
JavaScript:      no
Pages:           2
Encrypted:       no
Page size:       595.389 x 841.663 pts (A4)
Page rot:        0
File size:       243067 bytes
Optimized:       yes
PDF version:     1.4


name                                 type              encoding         emb sub uni object ID
------------------------------------ ----------------- ---------------- --- --- --- ---------
CGGDBH+AdvTTd3a5f740                 Type 1C           WinAnsi          yes yes no      91  0
CGGDBI+AdvTTd3a5f740+fb              Type 1C           Custom           yes yes yes     92  0
CGGDBJ+AdvTT9b12cd41                 Type 1C           WinAnsi          yes yes no      93  0
CGGDCK+AdvTT2c8ce45a                 Type 1C           WinAnsi          yes yes no      94  0
CGGDCL+AdvOT1ef757c0                 Type 1C           WinAnsi          yes yes no      95  0
CGGDCM+AdvOT1ef757c0+20              Type 1C           WinAnsi          yes yes no      96  0
CGGDCN+AdvOT1ef757c0+fb              Type 1C           Custom           yes yes yes     97  0
CGGDCO+AdvOT1ef757c0+22              Type 1C           Custom           yes yes yes    111  0
CGGGLJ+AdvTT9b12cd41+fb              Type 1C           Custom           yes yes yes    113  0
CGGGLK+AdvTTd168d80a.I               Type 1C           WinAnsi          yes yes no     114  0
CGGHAK+AdvTTd3a5f740+20              Type 1C           WinAnsi          yes yes no      27  0
CGGHAL+AdvTT58d178b9+03              Type 1C           Custom           yes yes yes     29  0
CGGGPJ+AdvOT7d6df7ab.I               Type 1C           WinAnsi          yes yes no      28  0


Jhove (Rel. 1.28.0, 2023-05-18)
 Date: 2025-07-16 02:41:06 CEST
 RepresentationInformation: fonc-14-1472463_2_.pdf
  ReportingModule: PDF-hul, Rel. 1.12.4 (2023-03-16)
  LastModified: 2025-07-15 16:39:09 CEST
  Size: 243067
  Format: PDF
  Version: 1.4
  Status: Well-Formed and valid
  SignatureMatches:
   PDF-hul
  MIMEtype: application/pdf
  Profile: Linearized PDF
  PDFMetadata: 
   Objects: 160
   FreeObjects: 1
   IncrementalUpdates: 1
   DocumentCatalog: 
    PageLayout: SinglePage
    PageMode: UseOutlines
    Outlines: 
     Item: 
      Title: Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies
      Destination: bmark_2104060663
      Children: 
       Item: 
        Title: Author contributions
        Destination: bmark_-1208584890
       Item: 
        Title: Conflict of interest
        Destination: bmark_1089982005
       Item: 
        Title: Publisher’s note
        Destination: bmark_-1256977648
       Item: 
        Title: References
        Destination: bmark_2090415954
   Info: 
    Title: Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies
    Author: Marcos de Lima
    Subject: de Lima M, Di Rocco A and Ribera J-M (2024) Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies. Front. Oncol. 14:1472463
    Keywords: chimeric antigen receptor (CAR T), leukemia, myeloma, lymphoma, toxicity
    CreationDate: Fri Aug 16 00:44:01 CEST 2024
    ModDate: Fri Aug 16 01:18:34 CEST 2024
   ID: 0x5c104f2af0685336a1e40ae62ec32d97, 0xd0312a78d2b420479480123796e981f0
   Filters: 
    FilterPipeline: FlateDecode
    FilterPipeline: DCTDecode
   Images: 
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 2919
      ImageHeight: 577
      BitsPerSample: 8
      BitsPerSampleUnit: integer
   Fonts: 
    Type1: 
     Font: 
      BaseFont: CGGDCM+AdvOT1ef757c0+20
      FontSubset: true
      FirstChar: 145
      LastChar: 150
      FontDescriptor: 
       FontName: CGGDCM+AdvOT1ef757c0+20
       Flags: Nonsymbolic
       FontBBox: -135, -187, 1010, 833
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: CGGDCN+AdvOT1ef757c0+fb
      FontSubset: true
      FirstChar: 1
      LastChar: 3
      FontDescriptor: 
       FontName: CGGDCN+AdvOT1ef757c0+fb
       Flags: Symbolic
       FontBBox: 0, -10, 781, 708
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: CGGDCO+AdvOT1ef757c0+22
      FontSubset: true
      FirstChar: 1
      LastChar: 1
      FontDescriptor: 
       FontName: CGGDCO+AdvOT1ef757c0+22
       Flags: Symbolic
       FontBBox: -135, -166, 697, 916
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: CGGGLJ+AdvTT9b12cd41+fb
      FontSubset: true
      FirstChar: 1
      LastChar: 1
      FontDescriptor: 
       FontName: CGGGLJ+AdvTT9b12cd41+fb
       Flags: Symbolic
       FontBBox: 0, 0, 854, 697
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: CGGGLK+AdvTTd168d80a.I
      FontSubset: true
      FirstChar: 46
      LastChar: 116
      FontDescriptor: 
       FontName: CGGGLK+AdvTTd168d80a.I
       Flags: Serif, Nonsymbolic
       FontBBox: -145, -208, 968, 875
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: CGGDBH+AdvTTd3a5f740
      FontSubset: true
      FirstChar: 42
      LastChar: 121
      FontDescriptor: 
       FontName: CGGDBH+AdvTTd3a5f740
       Flags: Serif, Nonsymbolic
       FontBBox: -52, -208, 916, 885
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: CGGHAK+AdvTTd3a5f740+20
      FontSubset: true
      FirstChar: 146
      LastChar: 146
      FontDescriptor: 
       FontName: CGGHAK+AdvTTd3a5f740+20
       Flags: Nonsymbolic
       FontBBox: -114, -166, 1062, 864
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: CGGDBI+AdvTTd3a5f740+fb
      FontSubset: true
      FirstChar: 1
      LastChar: 3
      FontDescriptor: 
       FontName: CGGDBI+AdvTTd3a5f740+fb
       Flags: Symbolic
       FontBBox: 0, 0, 906, 708
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: CGGGPJ+AdvOT7d6df7ab.I
      FontSubset: true
      FirstChar: 67
      LastChar: 118
      FontDescriptor: 
       FontName: CGGGPJ+AdvOT7d6df7ab.I
       Flags: Serif, Nonsymbolic
       FontBBox: -135, -250, 1000, 854
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: CGGDBJ+AdvTT9b12cd41
      FontSubset: true
      FirstChar: 40
      LastChar: 169
      FontDescriptor: 
       FontName: CGGDBJ+AdvTT9b12cd41
       Flags: Serif, Nonsymbolic
       FontBBox: -52, -208, 906, 875
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: CGGHAL+AdvTT58d178b9+03
      FontSubset: true
      FirstChar: 0
      LastChar: 0
      FontDescriptor: 
       FontName: CGGHAL+AdvTT58d178b9+03
       Flags: Symbolic
       FontBBox: -645, -354, 916, 895
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: CGGDCK+AdvTT2c8ce45a
      FontSubset: true
      FirstChar: 40
      LastChar: 121
      FontDescriptor: 
       FontName: CGGDCK+AdvTT2c8ce45a
       Flags: Serif, Nonsymbolic
       FontBBox: -52, -208, 947, 895
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: CGGDCL+AdvOT1ef757c0
      FontSubset: true
      FirstChar: 37
      LastChar: 122
      FontDescriptor: 
       FontName: CGGDCL+AdvOT1ef757c0
       Flags: Serif, Nonsymbolic
       FontBBox: -20, -250, 947, 854
       FontFile3: true
      Encoding: WinAnsiEncoding
   XMP: <x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="3.1-701">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about=""
            xmlns:dc="http://purl.org/dc/elements/1.1/">
         <dc:format>application/pdf</dc:format>
         <dc:creator>
            <rdf:Seq>
               <rdf:li>Marcos de Lima</rdf:li>
               <rdf:li>Alice Di Rocco</rdf:li>
               <rdf:li>Jose-Maria Ribera</rdf:li>
            </rdf:Seq>
         </dc:creator>
         <dc:description>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">de Lima M, Di Rocco A and Ribera J-M (2024) Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies. Front. Oncol. 14:1472463</rdf:li>
            </rdf:Alt>
         </dc:description>
         <dc:rights>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">Copyright © 2024 de Lima, Di Rocco and Ribera. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</rdf:li>
            </rdf:Alt>
         </dc:rights>
         <dc:subject>
            <rdf:Bag>
               <rdf:li>chimeric antigen receptor (CAR T)</rdf:li>
               <rdf:li>leukemia</rdf:li>
               <rdf:li>myeloma</rdf:li>
               <rdf:li>lymphoma</rdf:li>
               <rdf:li>toxicity</rdf:li>
            </rdf:Bag>
         </dc:subject>
         <dc:title>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies</rdf:li>
            </rdf:Alt>
         </dc:title>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/">
         <pdf:Keywords>chimeric antigen receptor (CAR T), leukemia, myeloma, lymphoma, toxicity</pdf:Keywords>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xapRights="http://ns.adobe.com/xap/1.0/rights/">
         <xapRights:Marked>True</xapRights:Marked>
         <xapRights:WebStatement>https://www.frontiersin.org/legal/copyright-statement</xapRights:WebStatement>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xap="http://ns.adobe.com/xap/1.0/">
         <xap:ModifyDate>2024-08-16T07:18:34+08:00</xap:ModifyDate>
         <xap:CreateDate>2024-08-16T06:44:01+08:00</xap:CreateDate>
         <xap:MetadataDate>2024-08-16T07:18:34+08:00</xap:MetadataDate>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xapMM="http://ns.adobe.com/xap/1.0/mm/">
         <xapMM:DocumentID>uuid:bf3fc4ab-9f4a-4a9a-8a4f-214112bb2d21</xapMM:DocumentID>
         <xapMM:InstanceID>uuid:9351fe4d-9209-4bef-aff3-609cf1bc71ee</xapMM:InstanceID>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
   Pages: 
    Page: 
     Label: 1
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 221, 685, 500, 706
      Annotation: 
       Subtype: Link
       Rect: 221, 660, 455, 681
      Annotation: 
       Subtype: Link
       Rect: 221, 635, 475, 656
      Annotation: 
       Subtype: Link
       Rect: 236, 466, 528, 475
      Annotation: 
       Subtype: Link
       Rect: 360, 245, 386, 254
      Annotation: 
       Subtype: Link
       Rect: 235, 170, 267, 179
      Annotation: 
       Subtype: Link
       Rect: 49, 33, 119, 40
      Annotation: 
       Subtype: Link
       Rect: 500, 33, 545, 40
      Annotation: 
       Subtype: Link
       Rect: 49, 690, 125, 705
      Annotation: 
       Subtype: Link
       Rect: 60, 596, 147, 603
      Annotation: 
       Subtype: Link
       Rect: 49, 502, 152, 509
      Annotation: 
       Subtype: Link
       Rect: 89, 461, 182, 468
      Annotation: 
       Subtype: Link
       Rect: 49, 452, 99, 459
      Annotation: 
       Subtype: Link
       Rect: 458, 802, 483, 809
      Annotation: 
       Subtype: Link
       Rect: 474, 793, 524, 800
      Annotation: 
       Subtype: Link
       Rect: 454, 783, 541, 790
      Annotation: 
       Subtype: Link
       Rect: 49, 789, 221, 806
    Page: 
     Label: 2
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 196, 719, 201, 728
       Destination: 1
      Annotation: 
       Subtype: Link
       Rect: 210, 719, 290, 728
      Annotation: 
       Subtype: Link
       Rect: 63, 619, 123, 628
      Annotation: 
       Subtype: Link
       Rect: 63, 506, 106, 515
      Annotation: 
       Subtype: Link
       Rect: 63, 344, 118, 353
      Annotation: 
       Subtype: Link
       Rect: 318, 706, 355, 715
      Annotation: 
       Subtype: Link
       Rect: 487, 556, 491, 565
       Destination: 1
      Annotation: 
       Subtype: Link
       Rect: 497, 556, 502, 565
       Destination: 1
      Annotation: 
       Subtype: Link
       Rect: 266, 124, 290, 131
      Annotation: 
       Subtype: Link
       Rect: 49, 116, 106, 123
      Annotation: 
       Subtype: Link
       Rect: 62, 89, 163, 96
      Annotation: 
       Subtype: Link
       Rect: 317, 108, 398, 115
      Annotation: 
       Subtype: Link
       Rect: 455, 799, 545, 806
      Annotation: 
       Subtype: Link
       Rect: 49, 33, 119, 40
      Annotation: 
       Subtype: Link
       Rect: 500, 33, 545, 40
  Checksum: 09eb3f4a
   Type: CRC32
  Checksum: d2fb993580fab2a389e3d9e33b576722
   Type: MD5
  Checksum: 3b987ceb2f89d5f0fb173c807b9160c75973900f
   Type: SHA-1
  Checksum: 30db5872c9a1fbdbe62b30ff2613e30bc6252c40c6e8f19638ae2ee8183cebb9
   Type: SHA-256